Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DLGAP4 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | SCLY | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | KATNAL2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | UBQLN2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | MTMR6 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | C19orf67 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
mRNA | AC012005.1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | JPH1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | LASP1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | FKBP5 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |